Literature DB >> 11293470

Iron and protein sufficiency and red cell indices in phenylketonuria.

G L Arnold1, R Kirby, C Preston, E Blakely.   

Abstract

OBJECTIVE AND METHODS: We reviewed records of 41 children with treated phenylketonuria (PKU) in order to evaluate hematopoiesis and the effect of iron and protein sufficiency.
RESULTS: Six children (15%) were found to have anemia. Combined depletion of iron and protein stores was most likely to result in anemia, and two of the three children with this finding were anemic. Four children (10%) had evidence of iron deficiency without anemia (a precursor stage of iron deficiency anemia). Clinically significant iron depletion was found in older as well as younger children (well beyond the traditional infant/toddler deficient years). Plasma albumin was normal in all children and was not adequately sensitive to detect protein depletion sufficient to cause anemia or decreased growth. However, low plasma prealbumin (a more sensitive marker of protein sufficiency) correlated significantly with altered hematopoiesis or poor growth.
CONCLUSION: Compared to non-affected individuals, children with treated PKU make fewer red cells that have normal volume but increased hemoglobin per cell, resulting in a lower calculated hematocrit when measured by electronic cell counting. In the presence of iron or protein depletion, anemia may result. Routine monitoring of ferritin, complete blood counts and prealbumin are recommended for children with PKU at all ages.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11293470     DOI: 10.1080/07315724.2001.10719016

Source DB:  PubMed          Journal:  J Am Coll Nutr        ISSN: 0731-5724            Impact factor:   3.169


  6 in total

1.  Nutritional Consequences of Adhering to a Low Phenylalanine Diet for Late-Treated Adults with PKU : Low Phe Diet for Adults with PKU.

Authors:  Ingrid Wiig; Kristina Motzfeldt; Elin Bjørge Løken; Bengt Frode Kase
Journal:  JIMD Rep       Date:  2012-07-01

2.  Haematological findings in children with inborn errors of metabolism.

Authors:  Betul Tavil; Hatice Serapl Kalkanoglu Sivri; Turgay Coskun; Aytemiz Gurgey; Emel Ozyurek; Ali Dursun; Aysegul Tokatli; Cigdem Altay; Fatma Gumruk
Journal:  J Inherit Metab Dis       Date:  2006-08-12       Impact factor: 4.982

Review 3.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

Review 4.  Recommendations for the nutrition management of phenylalanine hydroxylase deficiency.

Authors:  Rani H Singh; Fran Rohr; Dianne Frazier; Amy Cunningham; Shideh Mofidi; Beth Ogata; Patricia L Splett; Kathryn Moseley; Kathleen Huntington; Phyllis B Acosta; Jerry Vockley; Sandra C Van Calcar
Journal:  Genet Med       Date:  2014-01-02       Impact factor: 8.822

5.  Status of nutrients important in brain function in phenylketonuria: a systematic review and meta-analysis.

Authors:  Gina A Montoya Parra; Rani H Singh; Aysun Cetinyurek-Yavuz; Mirjam Kuhn; Anita MacDonald
Journal:  Orphanet J Rare Dis       Date:  2018-06-26       Impact factor: 4.123

6.  Phenylketonuria: Our Experience in Nine Years at a Tertiary-level Referral Institute.

Authors:  Sadanandvalli R Chandra; Rita Christopher; Mane M Daryappa; Rashmi Devaraj
Journal:  J Pediatr Neurosci       Date:  2018 Jan-Mar
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.